Your session is about to expire
← Back to Search
Ovarian Tissue Cryopreservation for Pediatric Cancer Patients
Study Summary
This trial is designed to offer ovarian tissue cryopreservation to female pediatric patients with fertility threatening medical diagnoses.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a girl 17 years old or younger.My medical condition makes anesthesia and surgery riskier for me.My cancer treatment is not just for comfort care.
- Group 1: Ovarian tissue cryopreservation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being treated in the current experiment?
"Affirmative. The information listed on clinicaltrials.gov suggests that this trial is actively enrolling patients, and was initially posted in March of 2017 with a recent update occurring February 1st 2022. Presently the study seeks to recruit 100 subjects from one site."
Are there still opportunities for people to participate in this experiment?
"Affirmative. According to the clinicaltrials.gov website, this research project is still open for enrollment. It was initially posted on March 16th 2017 and has been recently updated on February 1st 2022. The goal of the study is to recruit 100 patients from one location."
Share this study with friends
Copy Link
Messenger